A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients

Molecular and Cellular Probes

Volumn 15, Issue 5, 2001, Pages 243-247

  Hatzaki, A ^a   Razi, E ^a   Anagnostopoulou, K ^a   Iliadis, K ^a   Kodaxis, A ^a   Papaioannou, D ^a   Labropoulos, S ^a   Vasilaki, M ^a   Kosmidis, P ^a   Saetta, A ^a   Mihalatos, M ^a   Nasioulas, G ^a  

^a Diagnostic and Therapeutic Centre of Athens   (Greece)

Author keywords

K ras; Mutagenic PCR; Mutation detection; NSCLC

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; EXON; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MUTAGENICITY; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0035196851     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.2001.0367     Document Type: Article

References (21)

1. Ras in human tumors
2. K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: A combined analysis of 881 cases
3. Mutational activation of the K-ras oncogene: A possible pathogenic factor in adenocarcinoma of the lung
4. Kirsten-ras oncogene activation as a prognostic marker in adenocarcinoma of the human lung
5. K-ras mutation: Early detection in molecular diagnosis and risk assessment of colorectal, pancreas and lung cancers - A review
6. A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides
7. p53 and RAS gene mutations in multiple myeloma
8. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): A study on pancreatic cancer
9. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
10. K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: Prospective study using two techniques with different detection limits
11. K-ras mutations in stools and tissue samples from patients with malignant and nonmalignant pancreatic diseases
12. Detection of K-ras mutations in spectrum from patients with adenocarcinoma of the lung by point-EXACCT
13. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer
14. Molecular pathologic substaging in 244 cases stage I non-small-cell lung cancer patients: Clinical implications
15. Detection and clinical correlations of ras gene mutations in human ovarian tumors
16. Detection of ras oncogene point mutations and simultaneous proliferative fraction estimation in gall-bladder cancer
17. K-ras mutation in Greek patients with poorly and moderately differentiated tumours of the lower intestinal tract
18. High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears
19. ras gene mutations in human endometrial carcinoma
20. Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: A prospective study
21. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma